Literature DB >> 22513334

Protein tyrosine phosphatases in lymphocyte activation and autoimmunity.

Inmoo Rhee1, André Veillette.   

Abstract

Lymphocyte activation must be tightly regulated to ensure sufficient immunity to pathogens and prevent autoimmunity. Protein tyrosine phosphatases (PTPs) serve critical roles in this regulation by controlling the functions of key receptors and intracellular signaling molecules in lymphocytes. In some cases, PTPs inhibit lymphocyte activation, whereas in others they promote it. Here we discuss recent progress in elucidating the roles and mechanisms of action of PTPs in lymphocyte activation. We also review the accumulating evidence that genetic alterations in PTPs are involved in human autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22513334     DOI: 10.1038/ni.2246

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  94 in total

1.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

2.  TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.

Authors:  Yutaka Arimura; Torkel Vang; Lutz Tautz; Scott Williams; Tomas Mustelin
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

3.  Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant.

Authors:  Tania Habib; Andrew Funk; Mary Rieck; Archana Brahmandam; Xuezhi Dai; Anil K Panigrahi; Eline T Luning Prak; Almut Meyer-Bahlburg; Srinath Sanda; Carla Greenbaum; David J Rawlings; Jane H Buckner
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

4.  Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells.

Authors:  T Katagiri; M Ogimoto; K Hasegawa; K Mizuno; H Yakura
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

5.  PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.

Authors:  L F Barcellos; S Caillier; L Dragone; M Elder; E Vittinghoff; P Bucher; R R Lincoln; M Pericak-Vance; J L Haines; A Weiss; S L Hauser; J R Oksenberg
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

6.  Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

Authors:  Tingting Sun; Nicola Aceto; Kristen L Meerbrey; Jessica D Kessler; Chunshui Zhou; Ilenia Migliaccio; Don X Nguyen; Natalya N Pavlova; Maria Botero; Jian Huang; Ronald J Bernardi; Earlene Schmitt; Guang Hu; Mamie Z Li; Noah Dephoure; Steven P Gygi; Mitchell Rao; Chad J Creighton; Susan G Hilsenbeck; Chad A Shaw; Donna Muzny; Richard A Gibbs; David A Wheeler; C Kent Osborne; Rachel Schiff; Mohamed Bentires-Alj; Stephen J Elledge; Thomas F Westbrook
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway.

Authors:  G A Koretzky; J Picus; M L Thomas; A Weiss
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

8.  SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells.

Authors:  Carla C Fowler; Lily I Pao; Joseph N Blattman; Philip D Greenberg
Journal:  J Immunol       Date:  2010-08-09       Impact factor: 5.422

9.  Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant.

Authors:  Johanna Aarnisalo; Andras Treszl; Peter Svec; Jane Marttila; Viveka Oling; Olli Simell; Mikael Knip; Anna Körner; Laszlo Madacsy; Barna Vasarhelyi; Jorma Ilonen; Robert Hermann
Journal:  J Autoimmun       Date:  2008-03-04       Impact factor: 7.094

10.  Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor.

Authors:  E D Cahir McFarland; T R Hurley; J T Pingel; B M Sefton; A Shaw; M L Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

View more
  108 in total

1.  Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine-1-phosphate receptor modulator.

Authors:  Ines C Angerer; Michael Hecker; Dirk Koczan; Luisa Roch; Jörg Friess; Annelen Rüge; Brit Fitzner; Nina Boxberger; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Alexander Winkelmann; Stefanie Meister; Uwe K Zettl
Journal:  CNS Neurosci Ther       Date:  2018-01-03       Impact factor: 5.243

2.  Adenovirus E3 protein modulates leukocyte functions.

Authors:  Niklas Arnberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-21       Impact factor: 11.205

3.  PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients.

Authors:  Yeniley Ruiz-Noa; Jorge Hernández-Bello; Mara A Llamas-Covarrubias; Claudia A Palafox-Sánchez; Edith Oregon-Romero; Pedro Ernesto Sánchez-Hernández; Maria Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Jose Francisco Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2018-11-06       Impact factor: 2.352

Review 4.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 5.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

Review 6.  SLE-associated risk factors affect DC function.

Authors:  Sun Jung Kim
Journal:  Curr Rheumatol Rep       Date:  2019-02-02       Impact factor: 4.592

7.  The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire.

Authors:  Genita Metzler; Xuezhi Dai; Christopher D Thouvenel; Socheath Khim; Tania Habib; Jane H Buckner; David J Rawlings
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

Review 8.  Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.

Authors:  Michael C Jensen; Stanley R Riddell
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  The chicken SLAM family.

Authors:  Christian Straub; Birgit C Viertlboeck; Thomas W Göbel
Journal:  Immunogenetics       Date:  2012-10-13       Impact factor: 2.846

10.  A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.

Authors:  Xuezhi Dai; Richard G James; Tania Habib; Swati Singh; Shaun Jackson; Socheath Khim; Randall T Moon; Denny Liggitt; Alejandro Wolf-Yadlin; Jane H Buckner; David J Rawlings
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.